DrugLogic^®, Inc. specializes in developing analytical tools for managing risks related to drug safety issues. DrugLogic is dedicated to designing, developing and delivering products that provide the latest innovations and state-of-the art solutions in support of pharmacovigilance and drug safety surveillance practices for both pharmaceutical and biotech companies. Its proprietary Qscan? product monitors both company proprietary adverse event data and publicly available data sources.


Management Team

Victor V. Gogolak,
Founder and Chief Executive Officer

Stephen P. Meyer,
Chief Financial Officer

Steven A. Wordham,
CTO / VP Operations

Long Doan,
Chief Architect

Paul R. Zapert,
Vice President of Sales and Marketing

Shaun Naughton,
Director of Western Operations

Tanya Cote,
Vice President, Administration

Nancy Jenkins,
Director of Contract Management